Search results
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Motley Fool via Yahoo Finance· 13 hours agoBoth drugs should have blockbuster potential. Vertex is evaluating inaxaplin in a phase 3 study...
Ozempic, Wegovy May Protect Kidney Health, New Research Finds
Health via Yahoo News· 5 days agoOzempic and Wegovy may be able to significantly reduce the risk of kidney complications, heart...
3 reasons you should see your doctor more often if you're over 35
Rolling Out· 13 hours agoAs we age, our bodies undergo various changes, and maintaining optimal health becomes increasingly...
Amino Acid Infusion Before Cardiac Surgery Reduced Acute Kidney Injury
MedPage Today· 4 days agoAn amino acid infusion reduced the occurrence of acute kidney injury (AKI) in adults undergoing...
ProKidney Corp. (NASDAQ:PROK) Director Buys $54,735,339.78 in Stock
ETF DAILY NEWS· 16 hours agoProKidney Corp. (NASDAQ:PROK – Get Free Report) Director Pablo G. Legorreta bought 22,617,909 shares of the business’s stock in a transaction dated Thursday, June 13th. The stock was acquired ...
What Usher Wants Parents With Kids With Type 1 Diabetes To Know
Parents· 5 days agoWhen Usher’s child was diagnosed with type 1 diabetes (T1D) at the age of 6, it was a shock for his...
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and...
Benzinga· 6 days agoWINSTON-SALEM, N.C., June 10, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. PROK ("ProKidney"), a leading late clinical-stage cellular therapeutics company focused on chronic & ...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
StreetInsider· 7 days agoThe efficacy estimandi showed 51.8%, 62.8% and 73.3% of participants taking 5 mg, 10 mg and 15 mg, respectively, achieved an absence of MASH with no worsening of fibrosis ...
Fresenius Medical Care (NYSE:FMS) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com initiated coverage on shares of Fresenius Medical Care (NYSE:FMS – Free Report) in a research note released on Sunday. The brokerage issued a strong-buy rating on the stock. Separately ...
Pivotal advancement in the treatment of small cell lung cancer
KHGI Nebraska TV· 2 days ago1 in 16 Americans will face a lung cancer diagnosis in their lifetime.Lung cancer is a complex and...